ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Following deal focused on Alzheimer's disease, AbbVie, Voyager Therapeutics expand collaboration to Parkinson's disease firstwordpharma
February 23, 2019AbbVie entered an exclusive global agreement with Voyager Therapeutics to develop vectorised antibodies directed at pathological species of alpha-synuclein for the potential treatment of Parkinson's disease and other diseases characterised by the abnormal -
Ex-Roche, Novartis, AstraZeneca leaders appointed to biotech roles pharmaphorum
January 17, 2019Three more big pharma R&D names have made the jump to biotech as Voyager Therapeutics, ImmunSYS and Immunocore announce they have appointed former execs from Roche, Novartis and AstraZeneca. -
Voyager Therapeutic's Parkinson's Trial Shows Positive Results
biospace
March 12, 2018Voyager Therapeutics,?headquartered in Cambridge, Massachusetts,?released?longer-term data from its ongoing Phase Ib clinical trial of VY-AADC in advanced Parkinson’s disease.
Pharma Sources Insight January 2025
